# Renoprotective Effects of Telbivudine in Chronic Hepatitis B

> **NCT03778567** · PHASE4 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 31 (actual)

## Conditions studied

- Hepatitis B, Chronic
- Chronic Kidney Diseases

## Interventions

- **DRUG:** Telbivudine

## Key facts

- **NCT ID:** NCT03778567
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-01
- **Primary completion:** 2016-06-16
- **Final completion:** 2018-05-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778567, "Renoprotective Effects of Telbivudine in Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03778567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*